Marco A. Chacón, President & CEO at Paragon Bioservices, Inc., who counts as many biotech as pharma customers, echoes this focus on the right capacity. He’s investing in his facilities to stay ahead of customers who are developing new vaccines, oncology drugs, and immunotherapies…

Outsourced Pharma